Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated review

27 Dec 2021

Abstract excerpt

COVID-19 has spread swiftly throughout the world posing a global health emergency. The significant numbers of deaths attributed to this pandemic have researchers battling to understand this new, dangerous virus. Researchers are looking to find possible treatment regimens and develop effective therapies. This study aims to provide an overview of published scientific information on potential treatments, emphasizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to PARP inhibition in cancer therapy
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34958163
DOI: 10.1002/rmv.2321

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated reviewPMID 34958163Read ↗

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemicSemantic proximity Read ↗

ACE2 partially dictates the host range and tropism of SARS-CoV-2Semantic proximity Read ↗

Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 ImmunopathologySemantic proximity Read ↗

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 InfectionSemantic proximity Read ↗

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations.Semantic proximity Read ↗

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroSemantic proximity Read ↗

A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible TargetsSemantic proximity Read ↗

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?Semantic proximity Read ↗

Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.Semantic proximity Read ↗

Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugsSemantic proximity Read ↗

SARS-CoV-2, ACE2 expression, and systemic organ invasionSemantic proximity Read ↗

Angiotensin Converting Enzyme 2 in Coronavirus Disease (COVID-19): Evidence from Bioinformatics AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.